Clinical Trial Update: A Study to Compare the Pharmacokinetics and Safety of Current Factor VIII Concentrate and Optivate® in Haemophilia A. [Phase 3]

View source ↗

Summary

Phase 3 trial comparing pharmacokinetics and safety of current Factor VIII concentrate versus Optivate in haemophilia A (completed).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Von Willebrand Disease

Drugs mentioned

• Optivate (von Willebrand factor concentrate (plasma-derived))

Snippet

Sponsor: Bio Products Laboratory | Conditions: Von Willebrand Disease | Phase 3 | Status: COMPLETED